UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000033351
Receipt No. R000037897
Scientific Title A Phase I study of Inotuzumab Ozogamicin as a single agent for pediatric patients in Japan with relapsed/refractory CD22-positive Acute Lymphoblastic Leukemia
Date of disclosure of the study information 2018/07/20
Last modified on 2018/09/18 16:56:40

No. Disposal Last modified on Item of update
1 Insert 2018/07/10 14:56:33
2 Update 2018/07/10 15:20:09 Interventions/Control_1
3 Update 2018/09/18 16:56:40 Recruitment status


Contact us.